Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles

References

• Cho JK, Hong JM, Han T, et al. (2013). Injectable and biodegradable poly(organophosphazene) hydrogel as a delivery system of docetaxel for cancer treatment. J Drug Target 6:564–73
   Google Scholar
• Conte C, Ungaro F, Maglio G, et al. (2013). Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer. J Control Release 1:40–52
   Google Scholar
• Fauzee NJ, Wang YL, Dong Z, et al. (2012). Novel hydrophilic taxane analogues inhibit growth of cancer cells. Asian Pac J Cancer Prev 2:563–7
   Google Scholar
• Fu Q, Sun J, Zhang W, et al. (2009). Nanoparticle albumin-bound (NAB) technology is a promising method for anti-cancer drug delivery. Recent Pat Anticancer Drug Discov 3:262–72
   Google Scholar
• Gan CW, Chien S, Feng SS. (2010). Nanomedicine: enhancement of chemotherapeutical efficacy of docetaxel by using a biodegradable nanoparticle formulation. Curr Pharm Des 21:2308–20
   Google Scholar
• Hawkins MJ, Soon-Shiong P, Desai N. (2008). Protein nanoparticles as drug carriers in clinical medicine. Adv Drug Deliv Rev 8:876–85
   Google Scholar
• Henni-Silhadi W, Deyme M, Boissonnade MM, et al. (2007). Enhancement of the solubility and efficacy of poorly water-soluble drugs by hydrophobically-modified polysaccharide derivatives. Pharm Res 12:2317–26
   Google Scholar
• Jiang S, Zhang Y, Zu Y, et al. (2010). Antitumor activities of extracts and compounds from water decoctions of Taxas cuspidata. Am J Chin Med 6:1107–14
   Google Scholar
• Jiang S, Zu Y, Fu Y, et al. (2008). Activation of the mitochondria-driven pathway of apoptosis in human PC-3 prostate cancer cells by a novel hydrophilic paclitaxel derivative, 7-xylosyl-10-deacetylpaclitaxel. Int J Oncol 1:103–11
   Google Scholar
• Kratz F. (2008). Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J Control Release 3:171–83
   Google Scholar
• Langer K, Balthasar S, Vogel V, et al. (2003). Optimization of the preparation process for human serum (HSA) nanoparticles. Int J Pharm 1-2:169–80
   Google Scholar
• Lejon S, Frick IM, Björck L, et al. (2004). Crystal structure and biological implications of bacterial albumin binding module in complex with human serumalbumin. J Biol Chem 41:42924–8
   Google Scholar
• Li X, Zhang J, Wang DK, et al. (2012). Preparation and in vitro properties of folate receptor targeting docetaxel-loaded amphiphilic copolymer-modified liposomes. Yao Xue Xue Bao 9:1219–26
   Google Scholar
• Lin W, Coombes AG, Davies MC, et al. (1993). Preparation of sub-100 nm human serum albuminnanospheres using a pH-coacerbation method. J Drug Target 3:237–43
   Google Scholar
• Low PS, Kularatne SA. (2009). Folate-targeted therapeutic and imaging agents and imaging agents for cancer. Curr Opin Chem Biol 3:256–62
   Google Scholar
• Manjappa AS, Goel PN, Vekataraju MP, et al. (2013). Is an alternative drug delivery system needed for docetaxel? The role of controlling epimerization in formulations and beyond. Pharm Res 10:2675–93
   Google Scholar
• Manoocheheri S, Darvishi B, Kamalinia G, et al. (2013). Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel. Daru 1:58
   Google Scholar
• Mi Y, Liu Y, Feng SS. (2011). Formulation of Docetaxel by folic acid-conjugated d-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2k)) micelles for targeted and synergistic chemotherapy. Biomaterials 16:4058–66
   Google Scholar
• Onishi K, Tsukiyama I, Katoh M, et al. (2013). Preparation of dealcholized onetaxotere®, docetaxel injection formulation and its pharmacokinetics in rats. Gan To Kagaku Ryoho 7:891–6
   Google Scholar
• Pradhan R, Poudel BK, Ramasamy T, et al. (2013). Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies. J Nanosci Nanotechnol 8:5948–56
   Google Scholar
• Ram BG, Uday BK. (2006). Nanoparticle technology for drug delivery. New York, USA: Taylor & Francis Group Inc. 85–6
   Google Scholar
• Ray A, Larson N, Pike DB, et al. (2011). Comparison of active and passive targeting of docetaxel for prostate cancer therapy by HPMA copolymer-RGDfK conjugates. Mol Pharm 4:1090–9
   Google Scholar
• Tan Q, Liu X, Fu X, et al. (2012). Current development in nanoformulations of docetaxel. Expert Opin Drug Deliv 8:975–90
   Google Scholar
• Tao W, Zeng X, Liu T, et al. (2013). Docetaxel-loaded nanoparticles based on star-shaped mannitol-core PLGA-TPGS diblock copolymer for breast cancer therapy. Acta Biomater 11:8910–20
   Google Scholar
• Torrecilla D, Lozano MV, Lallana E, et al. (2013). Anti-tumor efficacy of chitosan-g-poly(ethylene glycol) nanocapsules containing docetaxel: anti-TMEFF-2 functionalized nanocapsules vs. non-functionalized nanocapsules. Eur J Pharm Biopharm 3:330–7
   Google Scholar
• Wang D, Huang J, Wang X, et al. (2013a). The eradication of breast cancer cells and stem cells by 8-hydroxyquinoline-loaded hyaluronan modified mesoporous silica nanoparticle-supported lipid bilayers containing docetaxel. Biomaterials 31:7662–73
   Google Scholar
• Wang EC, Sinnott R, Werner ME, et al. (2013b). Differential cell responses to nanoparticle docetaxel and small molecule docetaxel at a sub-therapeutic dose range. Nanomedicine. [Epub ahead of print]. doi:10.1016/j.nano.2013.07.012
   Google Scholar
• Wang J, Liu W, Tu Q, et al. (2011). Folate-decorated hybrid polymeric nanoparticles for chemically and physically combined paclitaxel loading and targeted delivery. Biomacromolecules 1:228–34
   Google Scholar
• Weber C, Coester C, Kreuter J, et al. (2000). Desolvation process and surface characterization of protein nanoparticles. Int J Pharm 1:91–102
   Google Scholar
• Yang D, Van S, Shu Y, et al. (2012). Synthesis, characterization, and in vivo efficacy evaluation of PGG-docetaxel conjugate for potential cancer chemotherapy. Int J Nanomedicine 7:581–9
   PubMed Web of Science ®Google Scholar
• Yared JA, Tkaczuk KH. (2012). Update on taxane development: new analogs and new formulations. Drug Des Dev Ther 6:371–84
   PubMed Web of Science ®Google Scholar
• Zhao D, Zhao X, Zu Y, et al. (2010). Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles. Int J Nanomedicine 5:669–77
   PubMed Web of Science ®Google Scholar
• Zhao J, Mi Y, Feng SS. (2013). Targeted co-delivery of docetaxel and siPlk1 by herceptin-conjugated vitamin E TPGS based immunomicelles. Biomaterials 13:3411–21
   Google Scholar
• Zhao P, Astruc D. (2012). Docetaxel nanotechnology in anticancer therapy. Chem Med Chem 6:952–72
   Google Scholar
• Zeng X, Tao W, Mei L, et al. (2013). Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer. Biomaterials 25:6058–67
   Web of Science ®Google Scholar